Our Research activities never stop aiming always to the improvement of the quality of human life. In the Transdermal Drug Delivery System area, we develop nicotine Transdermal System (TDDS) for smoking cessation, while in the hypertension area, research has continued on the development of a TDDS for once-a-week administration. Moreover, research continued on the development of transdermal systems aimed at topical anesthesia and pain.
Various OTC products for the symptoms of common cold, oral hygiene, excessive excretion of shawl, as well as food supplements are also under development. We continued the development of product lines for “intensive care” such as anti-ageing products (against wrinkles, hyperpigmentation etc.).
We collaborate with many Research Institutes in Greece and abroad following closely the developments in the area of pharmaceutical research.
Our granted patent portfolio consists of a large number of patents covering the whole spectrum of our technologies and products, while many new patent applications are still under examination.
Examples of patents already approved are:
Moreover, many patent applications are still under evaluation worldwide.